XenImmune Therapeutics
Cambridge, United States· Est. 2018
Our innovative platform technology helps prevent cancer from evading the immune system by making tumors more immunogenic.
Private Company
Total funding raised: $5M
About
Our innovative platform technology helps prevent cancer from evading the immune system by making tumors more immunogenic.
AntibodiesBiologics
Funding History
1Total raised:$5M
Seed$5MMar 15, 2022